ZA200809998B - Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same - Google Patents

Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same

Info

Publication number
ZA200809998B
ZA200809998B ZA200809998A ZA200809998A ZA200809998B ZA 200809998 B ZA200809998 B ZA 200809998B ZA 200809998 A ZA200809998 A ZA 200809998A ZA 200809998 A ZA200809998 A ZA 200809998A ZA 200809998 B ZA200809998 B ZA 200809998B
Authority
ZA
South Africa
Prior art keywords
manufacturing
pharmaceutical composition
same
composition containing
stable pharmaceutical
Prior art date
Application number
ZA200809998A
Other languages
English (en)
Inventor
Lee Jin Young
Kim Nam Ho
Sung Jin-Heung
Um Key An
Kim Jae-Sun
Lee Nam Kyu
Jang Woo Jae
Oh Joon Gyo
Lee Yoon-Jung
Kim Woong Sik
Original Assignee
Sk Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39090946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200809998(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sk Chemicals Co Ltd filed Critical Sk Chemicals Co Ltd
Publication of ZA200809998B publication Critical patent/ZA200809998B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200809998A 2006-05-22 2008-11-25 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same ZA200809998B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20060045715 2006-05-22

Publications (1)

Publication Number Publication Date
ZA200809998B true ZA200809998B (en) 2009-11-25

Family

ID=39090946

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809998A ZA200809998B (en) 2006-05-22 2008-11-25 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same

Country Status (25)

Country Link
US (1) US8791152B2 (fr)
EP (1) EP2019664B1 (fr)
JP (1) JP5369332B2 (fr)
KR (2) KR100917809B1 (fr)
CN (1) CN101484137B (fr)
AU (1) AU2007252371B2 (fr)
BR (1) BRPI0711893A2 (fr)
CA (1) CA2653124C (fr)
CR (1) CR10485A (fr)
EA (1) EA014071B1 (fr)
EC (1) ECSP088951A (fr)
ES (1) ES2560641T3 (fr)
GE (1) GEP20115200B (fr)
GT (1) GT200800257A (fr)
HK (1) HK1128874A1 (fr)
IL (1) IL195459A (fr)
MA (1) MA30501B1 (fr)
MX (1) MX2008014948A (fr)
MY (1) MY149627A (fr)
NO (1) NO20084932L (fr)
NZ (1) NZ573202A (fr)
SV (1) SV2008003106A (fr)
TN (1) TNSN08475A1 (fr)
WO (1) WO2007136219A1 (fr)
ZA (1) ZA200809998B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534340B1 (fr) 2002-09-06 2011-11-16 Cerulean Pharma Inc. Polymeres a base de cyclodextrine pour l'administration de medicaments lies par liaison covalente
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
CN102014918A (zh) * 2007-04-20 2011-04-13 太阳医药工业有限公司 由微量沉淀产生的药学组合物
KR101502533B1 (ko) * 2007-11-22 2015-03-13 에스케이케미칼주식회사 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법
DK2231144T3 (da) * 2007-12-24 2014-10-13 Sun Pharma Advanced Res Co Ltd Nanodispersion
KR101053780B1 (ko) * 2008-02-29 2011-08-02 동아제약주식회사 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
KR20120050414A (ko) 2009-06-19 2012-05-18 썬 파마 어드밴스트 리서치 컴패니 리미티드 약물의 나노분산액 및 그의 제조 방법
CA2774015A1 (fr) * 2009-09-15 2011-03-24 Cerulean Pharma Inc. Conjugue de cdp-camptothecine, composition a distribution des orientations de particules et leurs utilisations
BR112012012210B8 (pt) 2009-11-23 2021-05-25 Cerulean Pharma Inc conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano
CA2798180A1 (fr) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Formulations non aqueuses de pro-emulsions a base de taxane et procedes de fabrication et d'utilisation de ces formulations
KR20120130740A (ko) * 2011-05-23 2012-12-03 에스케이케미칼주식회사 도세탁셀을 함유하는 액상 주사용 조성물
WO2012161520A2 (fr) * 2011-05-23 2012-11-29 에스케이케미칼 주식회사 Composition liquide injectable contenant du docétaxel
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2014055493A1 (fr) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Procédés et systèmes s'appliquant à la précipitation de polymères et à la génération de particules
EP2777691A1 (fr) * 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoïde - purification des excipients liquides
KR20140147336A (ko) * 2013-06-19 2014-12-30 에스케이케미칼주식회사 도세탁셀을 함유하는 액상 주사용 조성물
US10413517B2 (en) * 2014-06-12 2019-09-17 University Of Notre Dame Du Lac Composition and method for the treatment of neurological diseases and cerebral injury
JP2018512395A (ja) * 2015-03-16 2018-05-17 メリディアン ラボＭｅｒｉｄｉａｎｌａｂ タキサン−シクロデキストリン複合体を含む医薬組成物、作成方法、および使用方法
CN108366963A (zh) 2015-10-20 2018-08-03 B.布劳恩梅尔松根股份公司 包含丹曲林的水性组合物
EP3509569A1 (fr) * 2016-09-07 2019-07-17 Cadila Healthcare Limited Compositions stériles injectables comprenant médicament micellaires
CN113559277B (zh) * 2018-01-11 2023-11-17 比卡生物科技（广州）有限公司 一种注射用卡巴他赛组合物及其制备方法
WO2020019363A1 (fr) * 2018-07-25 2020-01-30 比卡生物科技（广州）有限公司 Composition de docétaxel pour injection et son procédé de préparation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003748A1 (fr) * 1991-08-13 1993-03-04 Temple University - Of The Commonwealth System Of Higher Education Modulation de la tension arterielle et inhibition de l'activation plaquettaire a l'aide d'un fragment de kininogene
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
US6133473A (en) * 1998-06-25 2000-10-17 Rohm And Haas Company Synthesis of carbamate compounds
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
KR100310839B1 (ko) 1999-03-23 2001-10-12 정기련 안정성이 개선된 파크리탁셀 가용화 주사제 조성물
CA2373994A1 (fr) 1999-05-24 2000-11-30 Sonus Pharmaceuticals, Inc. Excipient en emulsion pour medicaments faiblement solubles
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
AU768022B2 (en) 1999-05-27 2003-11-27 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US20030157161A1 (en) * 2001-05-01 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
DE60216287T2 (de) * 2001-07-13 2007-05-31 Nanocarrier Co., Ltd. Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
KR20030041577A (ko) * 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
JP2003342168A (ja) * 2002-05-24 2003-12-03 Nano Career Kk 注射用薬物含有ポリマーミセル製剤の製造方法
CN1502332A (zh) * 2002-11-25 2004-06-09 刘云清 抗癌药紫杉醇自乳化固体纳米粒——注射用紫杉醇的制备方法
US20050255164A1 (en) * 2002-08-15 2005-11-17 Yunging Liu Solid nano pharmaceutical formulation and preparation method thereof
US20040127551A1 (en) 2002-12-27 2004-07-01 Kai Zhang Taxane-based compositions and methods of use
JP2005075783A (ja) * 2003-09-01 2005-03-24 Otsuka Pharmaceut Factory Inc 難溶性化合物の可溶化または分散化用組成物
JP4929158B2 (ja) * 2005-03-14 2012-05-09 株式会社大塚製薬工場 難水溶性薬物を含有する医薬組成物

Also Published As

Publication number Publication date
CR10485A (es) 2009-03-02
IL195459A0 (en) 2009-08-03
JP2009538294A (ja) 2009-11-05
EP2019664B1 (fr) 2016-01-06
MX2008014948A (es) 2009-02-03
EP2019664A1 (fr) 2009-02-04
EA200870559A1 (ru) 2009-04-28
EA014071B1 (ru) 2010-08-30
GEP20115200B (en) 2011-04-11
BRPI0711893A2 (pt) 2012-01-10
NZ573202A (en) 2010-08-27
US20090163574A1 (en) 2009-06-25
IL195459A (en) 2013-09-30
NO20084932L (no) 2008-12-19
ECSP088951A (es) 2009-02-27
CA2653124A1 (fr) 2007-11-29
CN101484137A (zh) 2009-07-15
CN101484137B (zh) 2014-05-14
KR100983376B1 (ko) 2010-09-20
EP2019664A4 (fr) 2013-03-13
JP5369332B2 (ja) 2013-12-18
HK1128874A1 (zh) 2009-11-13
TNSN08475A1 (en) 2010-04-14
ES2560641T3 (es) 2016-02-22
MA30501B1 (fr) 2009-06-01
MY149627A (en) 2013-09-13
GT200800257A (es) 2010-10-19
US8791152B2 (en) 2014-07-29
AU2007252371A1 (en) 2007-11-29
KR100917809B1 (ko) 2009-09-18
KR20070112725A (ko) 2007-11-27
SV2008003106A (es) 2010-04-30
AU2007252371B2 (en) 2013-07-25
KR20090101145A (ko) 2009-09-24
CA2653124C (fr) 2014-04-22
WO2007136219A1 (fr) 2007-11-29

Similar Documents

Publication Publication Date Title
IL195459A0 (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL195861A0 (en) Thienopyrimidine derivatives and pharmaceutical compositions containing the same
EP2084519A4 (fr) Elaboration et fabrication avancées de médicaments
EP2081550A4 (fr) Revêtement de capsules avec des ingrédients pharmaceutiques actifs
SI3984528T1 (sl) Farmacevtski sestavki, ki vsebujejo nilotinib
EP2056835A4 (fr) Compositions pharmaceutiques et leurs utilisations
LT2957278T (lt) Stabili kompozicija, apimanti pthrp ir jos panaudojimas
GB2451409B (en) Production of band-driven packages and their components
EP2008628A4 (fr) Emballage destine a un seul article et son procede de fabrication
EP2057987A4 (fr) Composition pharmaceutique contenant une nanoparticule de statine encapsulée
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
EP2075010A4 (fr) Composition pharmaceutique contenant une inclusion de cyclodextrine/paclitaxel et procédé de fabrication
EP2030612A4 (fr) Composition pharmaceutique pour traiter des brûlures (et variantes) et procédés de fabrication (et variantes)
GB0610090D0 (en) Particulate drug compositions and their uses
EP2070919A4 (fr) Composé de spiroquinone et composition pharmaceutique
GB0614365D0 (en) Pharmaceutical compositions and their use
IL192844A0 (en) Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
IL196318A0 (en) (s)-(-)-amlodipine camsylate derivatives and pharmaceutical compositions containing
IL194906A0 (en) Triphenylmethylphosphonate ester derivatives and pharmaceutical compositions containing the same
EP2114404A4 (fr) Composé et composition pharmaceutiques
EP1888025A4 (fr) Composition de porteur de medicament du procede de formation de film de la partir de cette composition
ZA200805658B (en) Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
GB2457188B (en) Production of band-driven packages and their components